These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16173156)

  • 1. Discounting health effects in pharmacoeconomic evaluations: current controversies.
    Bos JM; Postma MJ; Annemans L
    Pharmacoeconomics; 2005; 23(7):639-49. PubMed ID: 16173156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discounting of health benefits in the pharmacoeconomic analysis of drug therapies: an issue for debate?
    Coyle D; Tolley K
    Pharmacoeconomics; 1992 Aug; 2(2):153-62. PubMed ID: 10146954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical arguments for the discounting of health consequences: where do we go from here?
    Lazaro A
    Pharmacoeconomics; 2002; 20(14):943-61. PubMed ID: 12403636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On discounting of health gains from human papillomavirus vaccination: effects of different approaches.
    Westra TA; Parouty M; Brouwer WB; Beutels PH; Rogoza RM; Rozenbaum MH; Daemen T; Wilschut JC; Boersma C; Postma MJ
    Value Health; 2012 May; 15(3):562-7. PubMed ID: 22583467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discounting in Economic Evaluations.
    Attema AE; Brouwer WBF; Claxton K
    Pharmacoeconomics; 2018 Jul; 36(7):745-758. PubMed ID: 29779120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discounting in the economic evaluation of health care interventions.
    Krahn M; Gafni A
    Med Care; 1993 May; 31(5):403-18. PubMed ID: 8501989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discounting in the evaluation of the cost-effectiveness of a vaccination programme: A critical review.
    Jit M; Mibei W
    Vaccine; 2015 Jul; 33(32):3788-94. PubMed ID: 26144897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discounting in decision making: the consistency argument revisited empirically.
    Brouwer WB; van Exel NJ
    Health Policy; 2004 Feb; 67(2):187-94. PubMed ID: 14720636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Values in Time Discounting.
    Heilmann C
    Sci Eng Ethics; 2017 Oct; 23(5):1333-1349. PubMed ID: 28812205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discounting in cost-utility analysis of healthcare interventions: reassessing current practice.
    Cohen BJ
    Pharmacoeconomics; 2003; 21(2):75-87. PubMed ID: 12515570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulating evidence for the case of differential discounting.
    Postma MJ; Parouty M; Westra TA
    Expert Rev Clin Pharmacol; 2013 Jan; 6(1):1-3. PubMed ID: 23272787
    [No Abstract]   [Full Text] [Related]  

  • 12. Time preferences for health in northern Tanzania: an empirical analysis of alternative discounting models.
    Robberstad B; Cairns J
    Pharmacoeconomics; 2007; 25(1):73-88. PubMed ID: 17192119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discounting in cost-effectiveness analysis of healthcare programmes.
    Katz DA; Welch HG
    Pharmacoeconomics; 1993 Apr; 3(4):276-85. PubMed ID: 10146991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a healthier discount procedure.
    Klock RM; Brouwer WB; Annemans LJ; Bos JM; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2005 Feb; 5(1):59-63. PubMed ID: 19807560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The practice of discounting in economic evaluations of healthcare interventions.
    Smith DH; Gravelle H
    Int J Technol Assess Health Care; 2001; 17(2):236-43. PubMed ID: 11446135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discounting in health care decision-making: time for a change?
    Sheldon TA
    J Public Health Med; 1992 Sep; 14(3):250-6. PubMed ID: 1419202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reviewing and piloting methods for decreasing discount rates; someone, somewhere in time.
    Parouty MB; Krooshof DG; Westra TA; Pechlivanoglou P; Postma MJ
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):523-47. PubMed ID: 23977978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relevance of pharmacoeconomic analyses to price and reimbursement decisions in Austria].
    Führlinger S
    Wien Med Wochenschr; 2006 Dec; 156(23-24):612-8. PubMed ID: 17211765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discounting and decision making in the economic evaluation of health-care technologies.
    Claxton K; Paulden M; Gravelle H; Brouwer W; Culyer AJ
    Health Econ; 2011 Jan; 20(1):2-15. PubMed ID: 21154521
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.